Stablepharma Limited

Stablepharma Limited

Biotechnology Research

Bath, NE Somerset 2,438 followers

Stablepharma develops fridge-free, extended shelf-life versions of vaccines and pharmaceuticals to reduce waste and CO2.

About us

Stablepharma Ltd is an innovative biopharmaceutical company developing a pipeline of fridge-free vaccine and pharmaceutical products. Stablepharma was founded with a simple purpose; to use its novel technology to dramatically improve health outcomes for those adults and children most at risk of death and disability caused by vaccine preventable diseases. StablevaX is an adaptable fridge-free technology which offers a greatly extended shelf-life, reduces vaccine wastage and CO2 emissions of the global cold-chain. The WHO estimate that approximately 50% of all vaccines manufactured are wasted due to failures in the global cold chain (distribution and storage of vaccines). Stablepharma aims to ensure that a proportion of vital vaccines and pharmaceutical products can be removed from the refrigerated cold chain and stored for months or even years at room temperature. Stablepharma is developing the worlds first fridge-free vaccine, SPVX02 for Tetanus diphtheria, a pharmaceutical product for the prevention of Tetanus and Diphtheria.

Website
https://www.stablepharma.com/
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Bath, NE Somerset
Type
Privately Held
Founded
2012
Specialties
Vaccine stabilisation, Improving vaccination programmes, Complying with WHO protocols, Improving vaccine shelf life, Reducing co2 emissions, and Reducing vaccine wastage

Locations

Employees at Stablepharma Limited

Updates

Similar pages

Browse jobs

Funding

Stablepharma Limited 10 total rounds

Last Round

Undisclosed

US$ 2.3M

See more info on crunchbase